Sangamo Therapeutics

Biotech · Public

Zinc finger protein-based gene editing therapeutics for neurological diseases

sangamo.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
18 granted · 22 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2691SD NANOSCIENCES, INC.——
2692OOMNI, INC.——
2693STEMMED, LTD——
2694Sangamo Therapeutics——
2695ARMA BIO, INC.——
2696IGE THERAPEUTICS, INC.——
2697SUDHIN BIOPHARMA COMPANY——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Press

1 article · matched on company name

Patents

USPTO · 18 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.